8953
Interim Analysis Of The United Kingdom Donanemab Controlled Access Programme: Early Patient Characteristics And Prescribing Patterns
Elsie Grace, Krista Schroeder, Rashna Khanna, Niraj Patel
Eli Lilly and Company
Poster Presenter: Krista Schroeder
